Cargando…
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105)
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459263/ https://www.ncbi.nlm.nih.gov/pubmed/35909244 http://dx.doi.org/10.1111/cas.15484 |
| _version_ | 1784786470409601024 |
|---|---|
| author | Maruyama, Dai Iida, Shinsuke Machida, Ryunosuke Kusumoto, Shigeru Fukuhara, Noriko Yamauchi, Nobuhiko Miyazaki, Kana Yoshimitsu, Makoto Kuroda, Junya Tsukamoto, Norifumi Tsujimura, Hideki Usuki, Kensuke Yamauchi, Takahiro Utsumi, Takahiko Mizuno, Ishikazu Takamatsu, Yasushi Nagata, Yasuyuki Ota, Shuichi Ohtsuka, Eiichi Hanamura, Ichiro Suzuki, Yasuhiro Yoshida, Shinichiro Yamasaki, Satoshi Suehiro, Youko Kamiyama, Yutaro Fukuhara, Suguru Tsukasaki, Kunihiro Nagai, Hirokazu |
| author_facet | Maruyama, Dai Iida, Shinsuke Machida, Ryunosuke Kusumoto, Shigeru Fukuhara, Noriko Yamauchi, Nobuhiko Miyazaki, Kana Yoshimitsu, Makoto Kuroda, Junya Tsukamoto, Norifumi Tsujimura, Hideki Usuki, Kensuke Yamauchi, Takahiro Utsumi, Takahiko Mizuno, Ishikazu Takamatsu, Yasushi Nagata, Yasuyuki Ota, Shuichi Ohtsuka, Eiichi Hanamura, Ichiro Suzuki, Yasuhiro Yoshida, Shinichiro Yamasaki, Satoshi Suehiro, Youko Kamiyama, Yutaro Fukuhara, Suguru Tsukasaki, Kunihiro Nagai, Hirokazu |
| author_sort | Maruyama, Dai |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9459263 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94592632022-09-12 Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) Maruyama, Dai Iida, Shinsuke Machida, Ryunosuke Kusumoto, Shigeru Fukuhara, Noriko Yamauchi, Nobuhiko Miyazaki, Kana Yoshimitsu, Makoto Kuroda, Junya Tsukamoto, Norifumi Tsujimura, Hideki Usuki, Kensuke Yamauchi, Takahiro Utsumi, Takahiko Mizuno, Ishikazu Takamatsu, Yasushi Nagata, Yasuyuki Ota, Shuichi Ohtsuka, Eiichi Hanamura, Ichiro Suzuki, Yasuhiro Yoshida, Shinichiro Yamasaki, Satoshi Suehiro, Youko Kamiyama, Yutaro Fukuhara, Suguru Tsukasaki, Kunihiro Nagai, Hirokazu Cancer Sci Letter to the Editor John Wiley and Sons Inc. 2022-07-31 2022-09 /pmc/articles/PMC9459263/ /pubmed/35909244 http://dx.doi.org/10.1111/cas.15484 Text en © 2022 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Maruyama, Dai Iida, Shinsuke Machida, Ryunosuke Kusumoto, Shigeru Fukuhara, Noriko Yamauchi, Nobuhiko Miyazaki, Kana Yoshimitsu, Makoto Kuroda, Junya Tsukamoto, Norifumi Tsujimura, Hideki Usuki, Kensuke Yamauchi, Takahiro Utsumi, Takahiko Mizuno, Ishikazu Takamatsu, Yasushi Nagata, Yasuyuki Ota, Shuichi Ohtsuka, Eiichi Hanamura, Ichiro Suzuki, Yasuhiro Yoshida, Shinichiro Yamasaki, Satoshi Suehiro, Youko Kamiyama, Yutaro Fukuhara, Suguru Tsukasaki, Kunihiro Nagai, Hirokazu Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title | Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title_full | Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title_fullStr | Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title_full_unstemmed | Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title_short | Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105) |
| title_sort | final analysis of randomized phase ii study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (jcog1105) |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459263/ https://www.ncbi.nlm.nih.gov/pubmed/35909244 http://dx.doi.org/10.1111/cas.15484 |
| work_keys_str_mv | AT maruyamadai finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT iidashinsuke finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT machidaryunosuke finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT kusumotoshigeru finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT fukuharanoriko finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT yamauchinobuhiko finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT miyazakikana finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT yoshimitsumakoto finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT kurodajunya finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT tsukamotonorifumi finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT tsujimurahideki finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT usukikensuke finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT yamauchitakahiro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT utsumitakahiko finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT mizunoishikazu finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT takamatsuyasushi finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT nagatayasuyuki finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT otashuichi finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT ohtsukaeiichi finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT hanamuraichiro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT suzukiyasuhiro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT yoshidashinichiro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT yamasakisatoshi finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT suehiroyouko finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT kamiyamayutaro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT fukuharasuguru finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT tsukasakikunihiro finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 AT nagaihirokazu finalanalysisofrandomizedphaseiistudyoptimizingmelphalanprednisolonebortezomibinmultiplemyelomajcog1105 |